Movement Alert｜3SBio Falls 5.79% in Regular Trading, Biotech Sector Under Broad Pressure as Short-Selling Ratio Climbs

Market Focus06-16

On June 16, 3SBio fell 5.79% in regular trading, trading at HK$16.11/share, with turnover of approximately HK$130 million. The decline came amid broad weakness across the biotechnology sector coupled with a notable rise in short-selling activity targeting the stock.

The biotech sector faced collective selling pressure, with peers AKESO falling 5.88%, Remegen declining 4.57%, and Co-Bridge Bio dropping 2.15%. Meanwhile, 3SBio's short-selling amount as a proportion of turnover surged to 18.74%, indicating heightened bearish positioning. Despite supportive actions — Chairman Lou Jing purchasing 516,000 shares at HK$15.25 per share on June 8, and Huatai-PineBridge Fund acquiring 636,500 shares at approximately HK$16.28 on June 10 — the stock remained under pressure from systemic sector rotation.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1137912142?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-16 10:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137912142","market":"hk","top_or_hot":-1,"title":"Movement Alert｜3SBio Falls 5.79% in Regular Trading, Biotech Sector Under Broad Pressure as Short-Selling Ratio Climbs","media":"Market Focus","content":"<p><p>On June 16, 3SBio fell 5.79% in regular trading, trading at HK$16.11/share, with turnover of approximately HK$130 million. The decline came amid broad weakness across the biotechnology sector coupled with a notable rise in short-selling activity targeting the stock.</p><p>The biotech sector faced collective selling pressure, with peers AKESO falling 5.88%, Remegen declining 4.57%, and Co-Bridge Bio dropping 2.15%. Meanwhile, 3SBio's short-selling amount as a proportion of turnover surged to 18.74%, indicating heightened bearish positioning. Despite supportive actions — Chairman Lou Jing purchasing 516,000 shares at HK$15.25 per share on June 8, and Huatai-PineBridge Fund acquiring 636,500 shares at approximately HK$16.28 on June 10 — the stock remained under pressure from systemic sector rotation.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜3SBio Falls 5.79% in Regular Trading, Biotech Sector Under Broad Pressure as Short-Selling Ratio Climbs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜3SBio Falls 5.79% in Regular Trading, Biotech Sector Under Broad Pressure as Short-Selling Ratio Climbs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-16 10:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 16, 3SBio fell 5.79% in regular trading, trading at HK$16.11/share, with turnover of approximately HK$130 million. The decline came amid broad weakness across the biotechnology sector coupled with a notable rise in short-selling activity targeting the stock.</p><p>The biotech sector faced collective selling pressure, with peers AKESO falling 5.88%, Remegen declining 4.57%, and Co-Bridge Bio dropping 2.15%. Meanwhile, 3SBio's short-selling amount as a proportion of turnover surged to 18.74%, indicating heightened bearish positioning. Despite supportive actions — Chairman Lou Jing purchasing 516,000 shares at HK$15.25 per share on June 8, and Huatai-PineBridge Fund acquiring 636,500 shares at approximately HK$16.28 on June 10 — the stock remained under pressure from systemic sector rotation.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01530","symbol_name":"三生制药","start_time":0,"source_url":"","article_id":"1137912142","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137912142","pubTimestamp":1781575308,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 16, 3SBio fell 5.79% in regular trading, trading at HK$16.11/share, with turnover of approximately HK$130 million. The decline came amid broad weakness across the biotechnology sector coupled...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01530":"三生制药"},"translate_title":"动向提示|三生制药常规交易跌5.79%沽空比率攀升生物科技板块普遍承压","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01530":1},"content_text":"On June 16, 3SBio fell 5.79% in regular trading, trading at HK$16.11/share, with turnover of approximately HK$130 million. The decline came amid broad weakness across the biotechnology sector coupled with a notable rise in short-selling activity targeting the stock.The biotech sector faced collective selling pressure, with peers AKESO falling 5.88%, Remegen declining 4.57%, and Co-Bridge Bio dropping 2.15%. Meanwhile, 3SBio's short-selling amount as a proportion of turnover surged to 18.74%, indicating heightened bearish positioning. Despite supportive actions — Chairman Lou Jing purchasing 516,000 shares at HK$15.25 per share on June 8, and Huatai-PineBridge Fund acquiring 636,500 shares at approximately HK$16.28 on June 10 — the stock remained under pressure from systemic sector rotation.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1137912142","isCrawlerRequest":true}